White House Says It Will Meet Vaccine Goals Despite Pause In Johnson & Johnson Use
The NPR Politics Podcast
00:00
Understanding Vaccine Risks and Government Transparency
This chapter addresses concerns about the Johnson & Johnson vaccine's rare blood clot risks while emphasizing health officials' reassurance regarding the low probability of such events. It also contrasts current and past administration's approaches to transparency in health communication, underscoring the significance of public trust in health decisions.
Play episode from 02:54
Transcript
